ArticleDepression and anxiety2025
Depression in Adolescence: Relevance of Serotonin Receptor Polymorphisms.
Article in Depression and anxiety, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Multilevel Mechanisms and Clinical Efficacy of Psilocybin in Depression Treatment: A Systematic Review.International journal of molecular sciences · 2026Pooled it
- From synapse to strategy: a bibliometric map of ionotropic glutamate receptors in depression.Naunyn-Schmiedeberg's archives of pharmacology · 2026Review
- An Overview of Depression Pathogenesis: Prevailing Hypotheses and Associated Neurobiological Underpinnings Primarily Evidenced by Rodent Studies.Depression and anxiety · 2026Review
- Integrative clinical and molecular insights into the comorbidity between depression and sleep apnea syndrome.Frontiers in psychiatry · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Depression in adolescence is influenced by the environment, family members, social relationships, and genetic factors. Gene polymorphisms of serotonin receptors were associated with mental/psychiatric disorders, including impulsive, aggressive, violent, antisocial or criminal conduct, schizophrenia, eating disorders, alexithymia, autism, and major depressive disorder (MDD). Few studies reported the association between serotonin receptor polymorphisms and depressive symptoms in nonclinical subjects. The present study aimed to evaluate the serotonin receptor polymorphisms in nonclinical adolescents presenting depressive symptoms. The results clearly demonstrated that nonclinical adolescents with severe depressive symptoms had a high concentration of GA + AA in the recessive model and of AA in the homozygous model of the rs6311 polymorphism. The data indicated that the A allele was associated with severe depressive symptoms. Moreover, the analysis highlighted a trend of association of TT + CT in the recessive model for rs6313 polymorphism and severe symptoms. In conclusion, our study confirms that the A allele for rs6311 represents a risk factor, and the allele T for rs6313 could be a possible risk factor for severe depressive symptoms. As a consequence, the allele G for rs6311 and the allele C for rs6313 could be protective against severe depressive symptoms. Therefore, it might be appropriate to work preventively on adolescents with the A allele for rs6311 and T allele for rs6313 polymorphism to reduce the possibility of developing depressive symptoms and to preserve mental health in young people.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.